Group 1 - The pharmaceutical sector experienced a collective rise in early trading, with the China Securities Hong Kong Stock Connect Pharmaceutical and Health Comprehensive Index increasing by 1.3% [1] - The China Securities Innovative Drug Industry Index and the China Securities Biotechnology Theme Index both rose by 1.0%, while the Hang Seng Hong Kong Stock Connect Innovative Drug Index increased by 0.7% [1] - The CSI 300 Pharmaceutical and Health Index saw a rise of 0.6%, and the Hang Seng Innovative Drug ETF (159316) recorded a net subscription of 11 million units in half a day [1] Group 2 - Global financing trends in the biopharmaceutical sector are showing signs of recovery, with 175 financing events occurring in September, disclosing a total financing amount of $10.2 billion, representing a year-on-year increase of 57% [1] - In the domestic market, there were 68 financing events, with a disclosed total amount of approximately $956 million, reflecting a year-on-year growth of about 337% [1]